These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 25145582)
1. Diverse chemotypes disrupt ion homeostasis in the Malaria parasite. Lehane AM; Ridgway MC; Baker E; Kirk K Mol Microbiol; 2014 Oct; 94(2):327-39. PubMed ID: 25145582 [TBL] [Abstract][Full Text] [Related]
2. Biochemical characterization and chemical inhibition of PfATP4-associated Na Rosling JEO; Ridgway MC; Summers RL; Kirk K; Lehane AM J Biol Chem; 2018 Aug; 293(34):13327-13337. PubMed ID: 29986883 [TBL] [Abstract][Full Text] [Related]
3. Spiroindolone NITD609 is a novel antimalarial drug that targets the P-type ATPase PfATP4. Turner H Future Med Chem; 2016; 8(2):227-38. PubMed ID: 26824174 [TBL] [Abstract][Full Text] [Related]
4. Na(+) regulation in the malaria parasite Plasmodium falciparum involves the cation ATPase PfATP4 and is a target of the spiroindolone antimalarials. Spillman NJ; Allen RJ; McNamara CW; Yeung BK; Winzeler EA; Diagana TT; Kirk K Cell Host Microbe; 2013 Feb; 13(2):227-37. PubMed ID: 23414762 [TBL] [Abstract][Full Text] [Related]
5. The malaria parasite cation ATPase PfATP4 and its role in the mechanism of action of a new arsenal of antimalarial drugs. Spillman NJ; Kirk K Int J Parasitol Drugs Drug Resist; 2015 Dec; 5(3):149-62. PubMed ID: 26401486 [TBL] [Abstract][Full Text] [Related]
6. Diverse antimalarials from whole-cell phenotypic screens disrupt malaria parasite ion and volume homeostasis. Dennis ASM; Rosling JEO; Lehane AM; Kirk K Sci Rep; 2018 Jun; 8(1):8795. PubMed ID: 29892073 [TBL] [Abstract][Full Text] [Related]